Dry fluorescence immunoassay test kit for amyloid-beta protein detection. Supports assessment of Alzheimer disease pathology.
Manufactured by
Nanjing, China
Lansion Biotechnology Co., Ltd.(Lansionbio) was established in Nanjing, China in 2016. As one high-tech enterprise and key technology-based enterprise, Lansionbio is committed to the research development, production, sales and service of in vitro diagnostic reagents and devices. Through the integrated multi-platform POCT workstation, it provides medical units and families with comprehensive solutions for on-site rapid detection, and has become a representative enterprise of the new generation of laboratory medicine industry ecology in China. Since 2020, Lansionbio has been actively involved in the prevention and control of the global COVID-19 epidemic, and its related products have obtained CE certification and product registration in many countries, and are exported to more than 50 countries and regions outside of China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
SHENZHEN ANQUN BIOTECH CO.,LTD.
China · 11 relevant products
Chongqing Kangjuquanhong Biotechnology Co.,Ltd.
China · 4 relevant products
Diazyme Laboratories, Inc.
United States · 6 relevant products
47 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 87 closest product alternatives
SHENZHEN ANQUN BIOTECH CO.,LTD. · China
Chemiluminescent assay kit for quantitative detection of beta amyloid 1-42 in patient samples. Designed for early diagnosis and monitoring of Alzheimer's disease and neurodegenerative disorders. Provides rapid, sensitive results using chemiluminescent immunoassay methodology for clinical laboratory use.
Chongqing Kangjuquanhong Biotechnology Co.,Ltd. · China
A diagnostic test kit for measuring β-amyloid protein 1-42 using magnetic microparticle chemiluminescence immunoassay method. Applied in dementia assessment.
Diazyme Laboratories, Inc. · United States
Quantitatively determines amyloid-beta 42 concentration in EDTA plasma using chemiluminescence analysis. Supports research in Alzheimer's disease and neurological assessment.
84 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products